Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Vecuronium recalled?

Not under an active recall. Vecuronium was recalled 12 times in the past — all now closed. Most recent: Jul 17, 2023.

Most common reason: Sterility / contamination (5 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Vecuronium. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Vecuronium recalls on record

none so far in 2026; 12 on record, newest first
Class II · Moderate risk

vecuronium

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-1048-2023
Class II · Moderate risk

Vecuronium Bromide for Injection

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Terminated Sterility / contamination Teva Pharmaceuticals USA NDC 0703-2914-01 D-0279-2021
Class III · Low risk

Vecuronium bromide for Injection

Failed impurities/ degradation specifications: Out-of-specification (OOS) result for USP related compound F at the 12 month stability test station.

Terminated Impurity / degradation Fresenius Kabi USA, LLC NDC 63323-781-10 D-0426-2018
Class II · Moderate risk

Vecuronium Bromide active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-951-2015
Class II · Moderate risk

VECURONIUM Bromide for Injection

CGMP Deviations: product was not manufactured under current good manufacturing practices which contributed to Failed Impurities/Degradation Specifications as a high out of specification impurity result was detected during routine quality testing of stability samples.

Terminated Impurity / degradation Sagent Pharmaceuticals Inc NDC 25021-657-10 D-605-2013